126 related articles for article (PubMed ID: 34162733)
1. Integrative Cistromic and Transcriptomic Analyses Identify CREB Target Genes in Cystic Renal Epithelial Cells.
Liu Z; Liu Y; Dang L; Geng M; Sun Y; Lu Y; Fang Z; Xiong H; Chen Y
J Am Soc Nephrol; 2021 Oct; 32(10):2529-2541. PubMed ID: 34162733
[TBL] [Abstract][Full Text] [Related]
2. cAMP-Induced Nuclear Condensation of CRTC2 Promotes Transcription Elongation and Cystogenesis in Autosomal Dominant Polycystic Kidney Disease.
Mi Z; Song Y; Wang J; Liu Z; Cao X; Dang L; Lu Y; Sun Y; Xiong H; Zhang L; Chen Y
Adv Sci (Weinh); 2022 Apr; 9(10):e2104578. PubMed ID: 35037420
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of histone deacetylase 6 activity reduces cyst growth in polycystic kidney disease.
Cebotaru L; Liu Q; Yanda MK; Boinot C; Outeda P; Huso DL; Watnick T; Guggino WB; Cebotaru V
Kidney Int; 2016 Jul; 90(1):90-9. PubMed ID: 27165822
[TBL] [Abstract][Full Text] [Related]
4. Nuclear Condensation of CDYL Links Histone Crotonylation and Cystogenesis in Autosomal Dominant Polycystic Kidney Disease.
Dang L; Cao X; Zhang T; Sun Y; Tian S; Gong T; Xiong H; Cao P; Li Y; Yu S; Yang L; Zhang L; Liu T; Zhang K; Liang J; Chen Y
J Am Soc Nephrol; 2022 Sep; 33(9):1708-1725. PubMed ID: 35918147
[TBL] [Abstract][Full Text] [Related]
5. Identification of pathological transcription in autosomal dominant polycystic kidney disease epithelia.
Friedrich S; Müller H; Riesterer C; Schüller H; Friedrich K; Wörner CL; Busch T; Viau A; Kuehn EW; Köttgen M; Hofherr A
Sci Rep; 2021 Jul; 11(1):15139. PubMed ID: 34301992
[TBL] [Abstract][Full Text] [Related]
6. Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease.
Chen L; Zhou X; Fan LX; Yao Y; Swenson-Fields KI; Gadjeva M; Wallace DP; Peters DJ; Yu A; Grantham JJ; Li X
J Clin Invest; 2015 Jun; 125(6):2399-412. PubMed ID: 25961459
[TBL] [Abstract][Full Text] [Related]
7. Polycystin-1 regulates amphiregulin expression through CREB and AP1 signalling: implications in ADPKD cell proliferation.
Aguiari G; Bizzarri F; Bonon A; Mangolini A; Magri E; Pedriali M; Querzoli P; Somlo S; Harris PC; Catizone L; Del Senno L
J Mol Med (Berl); 2012 Nov; 90(11):1267-82. PubMed ID: 22570239
[TBL] [Abstract][Full Text] [Related]
8. Renal expression of JAK2 is high in polycystic kidney disease and its inhibition reduces cystogenesis.
Patera F; Cudzich-Madry A; Huang Z; Fragiadaki M
Sci Rep; 2019 Mar; 9(1):4491. PubMed ID: 30872773
[TBL] [Abstract][Full Text] [Related]
9. Ectopic Phosphorylated Creb Marks Dedifferentiated Proximal Tubules in Cystic Kidney Disease.
Puri P; Schaefer CM; Bushnell D; Taglienti ME; Kreidberg JA; Yoder BK; Bates CM
Am J Pathol; 2018 Jan; 188(1):84-94. PubMed ID: 29107072
[TBL] [Abstract][Full Text] [Related]
10. The regulatory 1α subunit of protein kinase A modulates renal cystogenesis.
Ye H; Wang X; Constans MM; Sussman CR; Chebib FT; Irazabal MV; Young WF; Harris PC; Kirschner LS; Torres VE
Am J Physiol Renal Physiol; 2017 Sep; 313(3):F677-F686. PubMed ID: 28615245
[TBL] [Abstract][Full Text] [Related]
11. Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells.
Belibi FA; Reif G; Wallace DP; Yamaguchi T; Olsen L; Li H; Helmkamp GM; Grantham JJ
Kidney Int; 2004 Sep; 66(3):964-73. PubMed ID: 15327388
[TBL] [Abstract][Full Text] [Related]
12. Characterisation of transcription factor profiles in polycystic kidney disease (PKD): identification and validation of STAT3 and RUNX1 in the injury/repair response and PKD progression.
Formica C; Malas T; Balog J; Verburg L; 't Hoen PAC; Peters DJM
J Mol Med (Berl); 2019 Dec; 97(12):1643-1656. PubMed ID: 31773180
[TBL] [Abstract][Full Text] [Related]
13. Defining cellular complexity in human autosomal dominant polycystic kidney disease by multimodal single cell analysis.
Muto Y; Dixon EE; Yoshimura Y; Wu H; Omachi K; Ledru N; Wilson PC; King AJ; Eric Olson N; Gunawan MG; Kuo JJ; Cox JH; Miner JH; Seliger SL; Woodward OM; Welling PA; Watnick TJ; Humphreys BD
Nat Commun; 2022 Oct; 13(1):6497. PubMed ID: 36310237
[TBL] [Abstract][Full Text] [Related]
14. Tubular STAT3 Limits Renal Inflammation in Autosomal Dominant Polycystic Kidney Disease.
Viau A; Baaziz M; Aka A; Mazloum M; Nguyen C; Kuehn EW; Terzi F; Bienaimé F
J Am Soc Nephrol; 2020 May; 31(5):1035-1049. PubMed ID: 32238474
[TBL] [Abstract][Full Text] [Related]
15. Role of keratinocyte growth factor in the pathogenesis of autosomal dominant polycystic kidney disease.
Mei C; Mao Z; Shen X; Wang W; Dai B; Tang B; Wu Y; Cao Y; Zhang S; Zhao H; Sun T
Nephrol Dial Transplant; 2005 Nov; 20(11):2368-75. PubMed ID: 16141466
[TBL] [Abstract][Full Text] [Related]
16. p21 is decreased in polycystic kidney disease and leads to increased epithelial cell cycle progression: roscovitine augments p21 levels.
Park JY; Schutzer WE; Lindsley JN; Bagby SP; Oyama TT; Anderson S; Weiss RH
BMC Nephrol; 2007 Aug; 8():12. PubMed ID: 17714589
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-β inhibits cystogenesis in human autosomal dominant polycystic kidney epithelial cells.
Elberg D; Jayaraman S; Turman MA; Elberg G
Exp Cell Res; 2012 Aug; 318(13):1508-16. PubMed ID: 22504005
[TBL] [Abstract][Full Text] [Related]
18. Immortalized epithelial cells from human autosomal dominant polycystic kidney cysts.
Loghman-Adham M; Nauli SM; Soto CE; Kariuki B; Zhou J
Am J Physiol Renal Physiol; 2003 Sep; 285(3):F397-412. PubMed ID: 12734101
[TBL] [Abstract][Full Text] [Related]
19. Double inhibition of cAMP and mTOR signalling may potentiate the reduction of cell growth in ADPKD cells.
de Stephanis L; Bonon A; Varani K; Lanza G; Gafà R; Pinton P; Pema M; Somlo S; Boletta A; Aguiari G
Clin Exp Nephrol; 2017 Apr; 21(2):203-211. PubMed ID: 27278932
[TBL] [Abstract][Full Text] [Related]
20. EP2 receptor mediates PGE2-induced cystogenesis of human renal epithelial cells.
Elberg G; Elberg D; Lewis TV; Guruswamy S; Chen L; Logan CJ; Chan MD; Turman MA
Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1622-32. PubMed ID: 17728378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
